Early prediction of a long-term outcome by neutrophil-FISH in patients with CML receiving imatinib mesylate

MeSH terms

• Antineoplastic Agents / therapeutic use*
• Benzamides
• Cytogenetic Analysis
• Humans
• Imatinib Mesylate
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
• Neutrophils / drug effects
• Neutrophils / pathology*
• Piperazines / therapeutic use*
• Pyrimidines / therapeutic use*
• Treatment Outcome